134 related articles for article (PubMed ID: 35982202)
1. Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Caramanna I; Klein M; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Reijneveld JC;
Qual Life Res; 2022 Nov; 31(11):3253-3266. PubMed ID: 35982202
[TBL] [Abstract][Full Text] [Related]
2. Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
Ediebah DE; Reijneveld JC; Taphoorn MJ; Coens C; Zikos E; Aaronson NK; Heimans JJ; Bottomley A; Klein M;
Qual Life Res; 2017 Apr; 26(4):869-880. PubMed ID: 27744512
[TBL] [Abstract][Full Text] [Related]
3. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
[TBL] [Abstract][Full Text] [Related]
4. The use of significant others as proxy raters of the quality of life of patients with brain cancer.
Sneeuw KC; Aaronson NK; Osoba D; Muller MJ; Hsu MA; Yung WK; Brada M; Newlands ES
Med Care; 1997 May; 35(5):490-506. PubMed ID: 9140337
[TBL] [Abstract][Full Text] [Related]
5. Does preoperative health-related quality of life predict survival in high-grade glioma patients? - a prospective study.
Haraldseide LM; Jakola AS; Solheim O; Sagberg LM
Br J Neurosurg; 2020 Feb; 34(1):28-34. PubMed ID: 31809598
[No Abstract] [Full Text] [Related]
6. Assessment of Executive Functioning in Patients with Meningioma and Low-Grade Glioma: A Comparison of Self-Report, Proxy-Report, and Test Performance.
van der Linden SD; Gehring K; De Baene W; Emons WHM; Rutten GM; Sitskoorn MM
J Int Neuropsychol Soc; 2020 Feb; 26(2):187-196. PubMed ID: 31699166
[TBL] [Abstract][Full Text] [Related]
7. [Cancer patients quality of life, measured by themselves and proxys].
Oliveira A; Pimentel FL
Acta Med Port; 2008; 21(2):125-34. PubMed ID: 18625091
[TBL] [Abstract][Full Text] [Related]
8. Cognition and health-related quality of life in long-term survivors of high-grade glioma: an interactive perspective from patient and caregiver.
Spoor JKH; Donders-Kamphuis M; Veenstra WS; van Dijk SA; Dirven CMF; Sillevis Smitt PAE; van den Bent MJ; Leenstra S; Satoer DD
Acta Neurochir (Wien); 2024 Apr; 166(1):166. PubMed ID: 38565800
[TBL] [Abstract][Full Text] [Related]
9. Reliability of health-related quality-of-life assessments made by older adults and significant others for health states of increasing cognitive impairment.
Bravo G; Sene M; Arcand M
Health Qual Life Outcomes; 2017 Jan; 15(1):4. PubMed ID: 28069027
[TBL] [Abstract][Full Text] [Related]
10. Patient-proxy agreement on health-related quality of life in juvenile fibromyalgia syndrome.
Gmuca S; Xiao R; Sherry DD
Pediatr Rheumatol Online J; 2019 May; 17(1):21. PubMed ID: 31072338
[TBL] [Abstract][Full Text] [Related]
11. Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033.
Dirven L; Reijneveld JC; Taphoorn MJB; Coens C; El-Badawy SA; Tzuk-Shina T; Bravo-Marques J; Back M; Stalpers LJA; Stupp R; Baumert BG; Seidel C
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):90-100. PubMed ID: 30716525
[TBL] [Abstract][Full Text] [Related]
12. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
[TBL] [Abstract][Full Text] [Related]
13. Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?
Oort Q; Dirven L; Sikkes SAM; Aaronson N; Boele F; Brannan C; Egeter J; Grant R; Klein M; Lips IM; Narita Y; Sato H; Sztankay M; Stockhammer G; Talacchi A; Uitdehaag BMJ; Reijneveld JC; Taphoorn MJB
Neurooncol Pract; 2022 Aug; 9(4):271-283. PubMed ID: 35855454
[TBL] [Abstract][Full Text] [Related]
14. Does Differential Item Functioning Jeopardize the Comparability of Health-Related Quality of Life Assessment Between Patients and Proxies in Patients with Moderate-to-Severe Traumatic Brain Injury?
Sébille V; Dubuy Y; Feuillet F; Blanchin M; Roquilly A; Cinotti R
Neurocrit Care; 2023 Oct; 39(2):339-347. PubMed ID: 36977961
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study.
Renovanz M; Hickmann AK; Nadji-Ohl M; Keric N; Weimann E; Wirtz CR; Singer S; Ringel F; Coburger J
Support Care Cancer; 2020 Nov; 28(11):5165-5175. PubMed ID: 32060706
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in Huntington's disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington's disease health-related quality of life questionnaire (HDQoL).
Hocaoglu MB; Gaffan EA; Ho AK
J Neurol; 2012 Sep; 259(9):1793-800. PubMed ID: 22392579
[TBL] [Abstract][Full Text] [Related]
17. Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire.
Sizoo EM; Dirven L; Reijneveld JC; Postma TJ; Heimans JJ; Deliens L; Pasman HR; Taphoorn MJ
J Neurooncol; 2014 Jan; 116(2):283-90. PubMed ID: 24162875
[TBL] [Abstract][Full Text] [Related]
18. Proxy reporting of quality of life using the EQ-5D.
Tamim H; McCusker J; Dendukuri N
Med Care; 2002 Dec; 40(12):1186-95. PubMed ID: 12458301
[TBL] [Abstract][Full Text] [Related]
19. Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients.
Dirven L; Musoro JZ; Coens C; Reijneveld JC; Taphoorn MJB; Boele FW; Groenvold M; van den Bent MJ; Stupp R; Velikova G; Cocks K; Sprangers MAG; King MT; Flechtner HH; Bottomley A
Neuro Oncol; 2021 Aug; 23(8):1327-1336. PubMed ID: 33598685
[TBL] [Abstract][Full Text] [Related]
20. Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports.
Rooney AG; McNamara S; Mackinnon M; Fraser M; Rampling R; Carson A; Grant R
J Neurooncol; 2013 May; 113(1):49-55. PubMed ID: 23436131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
